← back to search

Silvia Deaglio

Amsterdam University Medical Centers · IT
Area of research
Genetics · Physiology
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Calcium signaling and nucleotide metabolism, Adenosine and Purinergic Signaling, and Immune Cell Function and Interaction.
h-index
68
citations
17,640
works
474
NIH funding
primary concept
Medicine
email

Recent publications

<i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
Blood Cancer Discovery 2022cited by 27position: middledoi
Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma
International Journal of Molecular Sciences 2022cited by 16position: middledoi
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient–derived xenograft mouse models
Blood 2021cited by 88position: lastdoi
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation
Cell Reports 2021cited by 59position: middledoi
NOTCH1 drives immune-escape mechanisms in B cell malignancies
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 2position: middledoi
Biological and clinical implications of <i>BIRC3</i> mutations in chronic lymphocytic leukemia
Haematologica 2019cited by 84position: middledoi
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
Proceedings of the National Academy of Sciences 2019cited by 37position: middledoi
Genome-Wide Study Updates in the International Genetics and Translational Research in Transplantation Network (iGeneTRAiN)
Frontiers in Genetics 2019cited by 30position: middledoi
The genetics of nodal marginal zone lymphoma
Blood 2016cited by 178position: middledoi
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death
Scientific Reports 2016cited by 56position: middledoi
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts
Blood 2015cited by 111position: middledoi
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
Blood 2014cited by 182position: lastdoi
The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma
Leukemia 2014cited by 96position: middledoi
Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states
Journal of Molecular Medicine 2013cited by 78position: lastdoi
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism
Haematologica 2013cited by 53position: lastdoi
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells
Leukemia 2012cited by 94position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2013–2021)Nicoletta Vitale · University of Turin4 papers (2015–2022)Davide Rossi · Istituto Oncologico della Svizzera Italiana4 papers (2012–2014) · 4 papers (2013–2015)Gianluca Gaïdano · Università degli Studi del Piemonte Orientale “Amedeo Avogadro”4 papers (2012–2014)Giorgio Inghirami · Cornell University3 papers (2014–2015)Tiziana Vaisitti · Ospedale Regina Margherita3 papers (2012–2021) · 3 papers (2013–2014)Andrew V. Schally · Bruce W. Carter VA Medical Center2 papers (2019–2022) · 2 papers (2014–2015)Paolo Pinton · Tufts University2 papers (2016–2021) · 2 papers (2012–2014) · 2 papers (2019–2022)Renzhi Cai · Shanghai Municipal Center For Disease Control Prevention2 papers (2019–2022)Iacopo Gesmundo · Universidade de Santiago de Compostela2 papers (2019–2022)Chiara Riganti · Indiana University School of Medicine2 papers (2019–2021) · 2 papers (2012–2013) · 2 papers (2014–2015)Ezio Ghigo · Diabetes Australia2 papers (2019–2022)Roberto Piva · New York University2 papers (2014–2015)